Contract 36E79723D0015
Mylan Pharmaceuticals Inc · Department Of Veterans Affairs · January 24, 2025
Mylan Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on January 24, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 31, 2025. If all options are exercised, the contract could reach $8.35 million.
Contract details
- PIID
- 36E79723D0015
- Award type
- Indefinite Delivery / Requirements
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- January 24, 2025
- Latest action
- December 31, 2025
Description
2026 SUBCONTRACTING PLAN EFFECTIVE JANUARY 1, 2026 THROUGH DECEMBER 31, 2026 FOR CLOZAPINE TABLETS WITH MYLAN PHARMACEUTICALS.
Modification timeline
-
December 31, 2025Mod P00008 · Add Subcontracting Plan$0
-
December 18, 2025Mod P00007 · Exercise An OptionEXERCISE OPTION YEAR 3 EFFECTIVE MARCH 4, 2026 THROUGH MARCH 3, 2027 FOR CLOZAPINE TABLETS WITH MYLAN PHARMACEUTICALS. PRICES REMAIN UNCHANGED.$0
-
January 24, 2025Mod P00006$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79723D0015?
Contract 36E79723D0015 is a federal contract awarded to Mylan Pharmaceuticals Inc by Department Of Veterans Affairs on January 24, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36E79723D0015?
Mylan Pharmaceuticals Inc won contract 36E79723D0015 from Department Of Veterans Affairs.
How much is contract 36E79723D0015 worth?
Contract 36E79723D0015 has obligated $0 to date but carries a potential ceiling of $8.35 million if fully funded and all options are exercised.